Novacyt announced recently that its molecular testing division, Primerdesign, has inked an exclusive supply agreement with Genesis Diagnostics.

Stilla Technologies announced recently that it has completed a €16 million ($18.3 million) Series A financing round led by Illumina Ventures.

Bionano Genomics reported a 3 percent increase in third-quarter revenues after the market close recently.

PerkinElmer Genomics has chosen BioDiscovery's NxClinical software for genomic data analysis for its services, BioDiscovery announced recently.

WuXi NextCode said today that it has closed a $200 million Series C financing round.

LGC announced today that it has acquired SeraCare Life Sciences, a provider of quality control materials for the infectious disease testing and next-generation sequencing markets.

Stilla Technologies announced today that it has completed a €16 million ($18.3 million) Series A financing round led by Illumina Ventures.

Agilent Technologies reported after the close of the market on Monday that its fourth quarter revenues grew 9 percent year over year.

The global genotyping market is projected to reach USD 31.9 billion by 2023 from USD 11.8 billion in 2018, at a CAGR of 22.0%.

BioM¨¦rieux, the international leader in in vitro diagnostics, today announced the acquisition of a controlling stake in Suzhou Hybiome Biomedical Engineering Co. Ltd.

NEW YORK (GenomeWeb) ¨C Illumina plans to acquire Pacific Biosciences for approximately $1.2 billion in cash, the companies said on Thursday.

This story has been amended to correct errors and remove references to unrelated legal cases.

Jiankui He£ºHuman embryo editing

Antimicrobial resistance (AMR) threats to patient health are becoming more widely recognized and diagnostics manufacturers are making significant progress in combatting the overuse of antibiotics.

Nearly 1,000 devices are included in a recall of GE Healthcare's Millennium Nuclear Medical Systems after the top detector of one system detached and fell onto the detector below.